Chijioke Val Okeke

ABSTRACT Aim To evaluate the impact of a comprehensive set of social determinants of health (SDOH) on treatments, timing, and key biomarker testing for early-stage non-small cell lung cancer (NSCLC). Methods Patients with the first diagnosis of stage I–III NSCLC from 1 January 2015 to 15 October 2023 and treated at community health systems in the United States were eligible for this retrospective database study.

Introduction Spine-related disorders (SRD), including neck and back pain, are common health conditions that pose a major healthcare burden globally.1,2 Back pain is reported as one of the most common reasons for hospitalization visits in the United States,3 and up to 16% of American adults report having neck discomfort every year.4 Among the several management options for spine-related illnesses, opioid pharmacotherapy has become a widely used treatment method for alleviating chronic pain.5...